Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBX 1,062.50
-7.50 (-0.70%)
Sep 2, 2026, 4:35 PM GMT
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 8.94 billion as of September 2, 2026. Its market cap has decreased by -25.94% in one year.
Market Cap
8.94B
Enterprise Value
11.23B
Revenue
4.77B
Ranking
n/a
PE Ratio
19.09
Stock Price
1,062.50
ChartMarket Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 8.94B, an increase of 990.05%. That is a compound annual growth rate of 6.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 8.94B | -14.98% |
| Dec 31, 2025 | 10.51B | 21.60% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NIOX Group | 284.51M |
| AOTI, Inc. | 135.61M |
| EKF Diagnostics Holdings | 107.07M |
| Creo Medical Group | 57.83M |
| Inspiration Healthcare Group | 17.04M |
| RUA Life Sciences | 16.45M |
| Proteome Sciences | 4.91M |
| Surgical Innovations Group | 3.96M |